UK's NHS to roll out Vertex/CRISPR gene therapy for rare blood disorder

Crispr Therapeutics AG

08/08/2024 24:28

Aug 7 (Reuters) - Britain's National Health Service(NHS)
will begin rolling out Vertex Pharmaceuticals  VRTX.O  and
CRISPR Therapeutics' CRSP.BN  gene therapy to treat rare blood
disorder beta thalassemia, Vertex said in a statement on
Wednesday. 
    

 (Reporting by Gursimran Kaur in Bengaluru; Editing by Anil
D'Silva)
 ((GursimranKaur.Mehar@thomsonreuters.com;))